Use of aloe gel powder and composition of aloe gel powder and stachyose
Through the composition of aloe vera gel powder and sedrosen, the mass ratio is 1:30-20:1, the problem of insufficient anti-tumor application of aloe vera gel powder in the prior art is solved, and effective for colon cancer cells is achieved Inhibition and immunomodulation significantly improve the intestinal environment.
Patent Information
- Application Number
- PCT/CN2023/132287
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-04-30
- Filing Date
- 2023-11-17
- Publication Date
- 2024-11-07
AI Technical Summary
The prior art lacks the application of aloe vera gel powder in anti-tumor, especially anti-colorectal cancer, and there is no research on the activity of aloe vera gel powder and sedroose.
A composition of aloe gel powder and sedroose is provided with a mass ratio of 1:30-20:1 for the preparation of anti-tumor drugs, which significantly inhibit colon cancer cell growth through synergistic effects and regulate immunity and intestinal flora.
The composition has a good inhibitory effect on colon cancer cells and is non-toxic to macrophages. It significantly improves the spleen index and intestinal environment and improves the anti-tumor and immune regulation effect.
Smart Images

Figure PCTCN2023132287-FTAPPB-I100001 
Figure PCTCN2023132287-FTAPPB-I100002 
Figure PCTCN2023132287-FTAPPB-I100003
Abstract
Description
Application of aloe vera gel powder and its composition with stachyose Technical Field
[0001] The present invention belongs to the field of big health technology and relates to the application of aloe vera gel powder (AGF) and a composition thereof with stachyose (STC), and in particular to the application of aloe vera gel powder and a composition of aloe vera gel powder and stachyose in the preparation of foods, health products and medicines for anti-tumor, intestinal flora regulation and immune regulation. Background Art
[0002] Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, according to the World Health Organization. The most common cancers are breast, lung, colon, rectal, and prostate cancers. Some of the most common cancers, such as breast, cervical, oral, and colorectal cancers, have a high probability of being cured if detected early and treated according to best practices (World Health Organization, 2020).
[0003] Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related death worldwide. In 2020, there were 1.93 million cases of colorectal cancer and 916,000 deaths worldwide (World Health Organization, 2020). A healthy diet, including fruits and vegetables, can effectively prevent cancer, especially colorectal cancer.
[0004] Aloe vera gel powder (AGF) is obtained by peeling, extracting, depigmenting, filtering and freeze-drying or spray-drying the lily family plants Aloe vera L (Aloe vera L or Aloe barbadensis Miller), Aloe ferox Miller or other closely related plants.
[0005] Aloe vera has unique therapeutic and healing properties and has been used for centuries. To date, over 75 active ingredients have been identified from its gel, but the therapeutic effects have not been well correlated with each individual component. While polysaccharides from aloe vera leaf gel have some activity, these biological activities are believed to be due to the synergistic effects of the compounds contained within, rather than to a single chemical. Therefore, the activity of aloe vera gel powder, which retains intact aloe vera leaf gel extract, warrants further investigation, compared to using aloe vera polysaccharides alone.
[0006] Aloe vera gel powder is mainly used in skin and hair protection products in cosmetics. It has the effects of moisturizing, sun protection, deodorization, anti-obesity, softening skin, anti-inflammatory and anti-itching, analgesic, preventing acne, freckles, and lightening spots.
[0007] Stachyose (STC) is a naturally occurring tetrasaccharide belonging to the galactoside family of raffinose, a non-reducing functional oligosaccharide. Purely available, it is a slightly sweet white powder, with a sweetness 22% that of sucrose. Stachyose is not completely hydrolyzed by human digestive enzymes and can be fermented and utilized by intestinal bacteria, thereby regulating intestinal flora and improving energy metabolism. However, due to its small molecular weight and rapid metabolic breakdown, stachyose does not remain effective in the intestines for a long time. Combining it with aloe polysaccharides may prolong the effects of improving the intestinal environment, creating a synergistic effect.
[0008] There are no prior reports demonstrating that aloe vera gel powder has anti-tumor effects, particularly against colorectal cancer. There are also no reports on the activity of aloe vera gel powder combined with stachyose. We anticipate that the combination of aloe vera gel powder and stachyose will yield a more synergistic anti-tumor effect.
[0009] Summary of the Invention
[0010] In order to overcome the defects of the prior art, the present invention first provides the use of aloe vera gel powder in the preparation of anti-tumor, especially anti-colorectal cancer drugs.
[0011] Secondly, the present invention also provides a composition of aloe vera gel powder and stachyose, which has anti-tumor, immune-regulating and intestinal flora-regulating effects. Compared with using aloe vera gel powder alone, the composition has better anti-tumor activity and immune-regulating and intestinal flora-regulating effects.
[0012] The present invention is achieved through the following technical solutions:
[0013] The present invention provides application of aloe vera gel powder in preparing anti-tumor medicine.
[0014] Furthermore, the tumor includes but is not limited to colorectal tumor.
[0015] The invention provides a composition of aloe vera gel powder and stachyose. The composition comprises the aloe vera gel powder and the stachyose, and the mass ratio of the aloe vera gel powder to the stachyose is 1:30-20:1.
[0016] Furthermore, the mass ratio of aloe vera gel powder to stachyose is 1:9-3:7. At this ratio, the composition has a good inhibitory effect on colon cancer cells, has no significant toxicity to macrophages, and has a faster dissolution rate and a better taste.
[0017] Preferably, when the mass ratio of aloe vera gel powder to stachyose is 1:3-1:5, especially when the mass ratio of aloe vera gel powder to stachyose is 1:4, the composition has the strongest inhibitory effect on colon cancer cells and has no toxicity to macrophages.
[0018] The aloe vera gel powder of the present invention is derived from the lily family plants Aloe vera L. or Aloe barbadensis Miller, Aloe ferox Miller, or other closely related plants of the same genus. The aloe vera gel powder is prepared by decolorizing, freeze-drying, or spray-drying aloe vera juice.
[0019] The aloe vera gel powder of the present invention can be prepared using an extraction method known in the industry. The preparation process includes but is not limited to the following features:
[0020] Fresh aloe leaves are picked, washed, peeled, crushed, ground, centrifuged and filtered to produce aloe vera gel; food-grade pectinase is added for full enzymolysis; the leaves are crushed, ground and centrifuged to produce aloe vera juice; the aloe vera juice is decolorized and filtered, and then concentrated using a reverse osmosis process; the concentrated aloe vera juice is freeze-dried or spray-dried to produce aloe vera gel powder.
[0021] The aloe vera gel powder of the present invention has a polysaccharide content greater than or equal to 80 mg / g and an O-acetyl content greater than or equal to 90 mg / g.
[0022] The molecular structure of stachyose is a tetrasaccharide of "galactose-galactose-glucose-fructose", and the molecular formula is: C 24 H 42 O 21 , the relative molecular weight is 666.59, and the stachyose is food grade or medical grade edible stachyose.
[0023] The present invention has the following technical effects:
[0024] The aloe gel powder of the invention is prepared by decolorizing, freeze-drying or spray-drying aloe juice, and has a therapeutic effect on tumor-bearing mice.
[0025] Aloe vera gel powder and stachyose are combined to create an aloe vera gel powder-stachyose composition (AS), which exhibits synergistic anti-tumor effects. It significantly inhibits tumor growth and improves spleen function in CT26 tumor-bearing mice. This may be through immune regulation, improved intestinal flora, and increased levels of short-chain fatty acids (SCFAs).
[0026] Aloe vera gel powder has a unique sour taste and a poor taste. In addition, due to its high viscosity, the aloe vera gel powder dissolves slowly and easily clumps, making it difficult to take. Combining it with stachyose improves the above defects, increases the dissolution rate and improves the taste. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] FIG1 shows the toxic effects of aloe vera gel powder at different concentrations on RAW264.7 cells in Example 3;
[0028] ** : Compared with the control group, P < 0.01.
[0029] FIG2 shows the toxic effects of different concentrations of stachyose on RAW264.7 cells in Example 3;
[0030] ** : Compared with the control group, P < 0.01; * : Compared with the control group, P<0.05.
[0031] FIG3 shows the toxic effects of the compositions of aloe vera gel powder and stachyose in different formula ratios on RAW264.7 cells in Example 3;
[0032] ** : Compared with the control group, P < 0.01; ## : Compared with prescription 3, P<0.01.
[0033] FIG4 shows the toxic effects of aloe vera gel powder at different concentrations on CT26-WT cells in Example 3;
[0034] ** : Compared with the control group, P < 0.01; * : Compared with the control group, P<0.05.
[0035] FIG5 shows the toxic effects of different concentrations of stachyose on CT26-WT cells in Example 3.
[0036] FIG6 shows the toxic effects of the compositions of aloe vera gel powder and stachyose in different formula ratios on CT26-WT cells in Example 3;
[0037] ** : Compared with the control group, P < 0.01.
[0038] FIG7 shows the tumor volume on the 7th day after tumor cell inoculation in Example 4.
[0039] FIG8 shows the spleen index of tumor-bearing mice on day 21 after oral gavage in Example 4;
[0040] ** : Compared with the control group, P < 0.01.
[0041] FIG9 shows the tumor volumes of mice in each group after oral administration from day 1 to day 21 in Example 4;
[0042] ** : Compared with the results of the normal saline group, P<0.01.
[0043] Figure 10 shows the tumor mass of each group of mice after oral gavage on day 21 in Example 4;
[0044] ** : Compared with the results of the normal saline group, P < 0.01, # : Compared with the results of the combination group, P < 0.05, ## : Compared with the combination group, P < 0.01.
[0045] Figure 11 is a HE staining image of the tumors of mice in each group after oral gavage on day 21 in Example 4;
[0046] Figure 12 shows the serum levels of IL-1β, IL-10, IL-6, TNF-α, IgG, IgM, and IFN-γ in mice on day 21 after oral gavage in Example 4;
[0047] * : Compared with the results of the normal saline group, P<0.05, ** : Compared with the results of the normal saline group, P < 0.01, # : Compared with the results of the combination group, P < 0.05, ## : Compared with the combination group, P < 0.01.
[0048] Figure 13 is the flow cytometric detection of monocytes, DC cells, and CD8 in spleen tissue of mice on day 21 after oral gavage in Example 4. + T cells and Treg cells;
[0049] * : Compared with the results of the normal saline group, P<0.05, ** : Compared with the results of the normal saline group, P < 0.01, # : Compared with the results of the combination group, P < 0.05, ## : Compared with the combination group, P < 0.01.
[0050] Figure 14 is an analysis of Alpha diversity indicators in feces of mice after oral gavage on day 20 in Example 5;
[0051] * : Compared with the results of the normal saline group, P<0.05, ** : Compared with the results of the normal saline group, P<0.01.
[0052] Figure 15 is an OTU analysis of bacterial flora in feces of mice on day 20 after oral gavage in Example 5;
[0053] * : Compared with the results of the normal saline group, P<0.05, ** : Compared with the results of the normal saline group, P<0.01.
[0054] Figure 16 is an analysis of beneficial bacteria in feces of mice after oral gavage on day 20 in Example 5;
[0055] * : Compared with the results of the normal saline group, P<0.05.
[0056] Figure 17 is an analysis of harmful bacteria in feces of mice after oral gavage on day 20 in Example 5;
[0057] * : Compared with the results of the normal saline group, P<0.05.
[0058] Figure 18 is an analysis of short-chain fatty acids in feces of mice after oral gavage on day 20 in Example 6;
[0059] * : Compared with the results of the normal saline group, P<0.05, ** : Compared with the results of the normal saline group, P < 0.01, # : Compared with the results of the combination group, P < 0.05, ## : Compared with the combination group, P < 0.01. DETAILED DESCRIPTION
[0060] In order to better understand the essence of the present invention, the following embodiments are introduced, but the embodiments are only further explanations of the invention and are not limitations of the present invention. The following examples are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above examples. Any other changes, modifications, substitutions, combinations, and simplifications made without departing from the spirit and principles of the present invention shall be equivalent replacement methods and are included in the scope of protection of the present invention.
[0061] The aloe vera gel powder of the invention is food-grade aloe vera gel powder, wherein the polysaccharide content is 80 mg / g and the O-acetyl content is 90 mg / g.
[0062] Example 1: Effect of the ratio of aloe vera gel powder and stachyose composition on taste
[0063] (1) Composition formulation design and preparation of the composition
[0064] Weigh the corresponding mass fractions of aloe vera gel powder and stachyose according to Table 1, place in a suitable dry, sealed container, shake thoroughly to mix, and dispense 5g of the composition into moisture-proof packaging bags. Store in a transparent glass desiccator containing color-changing silica gel.
[0065] Table 1 Composition raw material ratio (mass ratio) prescription design table
[0066] (2) Evaluators and evaluation methods
[0067] Evaluator criteria: Healthy individuals aged 18-55 years were selected and signed informed consent for the taste experiment. Evaluators were preliminarily screened according to the Food Sensory Evaluation (edited by Han Beizhong et al., Food Sensory Evaluation (2nd edition), China Forestry Publishing House, 2016) based on their ① interest and motivation ② evaluator availability ③ attitude toward the evaluation object ④ knowledge and talent ⑤ health status ⑥ expression ability ⑦ personality characteristics. Evaluators who met the requirements were then examined on ① sensory function ② sensory sensitivity ③ ability to describe and express sensory reactions. Finally, 13 evaluators were selected.
[0068] The taste of the compositions was evaluated using a scoring method using a randomized block design, with samples presented one by one in a randomized order. Evaluators tasted the powdered composition directly and then swallowed it with 50 mL of purified water. The samples were then rated on an equally spaced categorical scale of 0-15 points. Evaluators rinsed their mouths with purified water before the experiment and between different formulations.
[0069] The scoring results are shown in Table 2.
[0070] Table 2 Overall evaluation of the taste of the prescription
[0071] (3) Test on the difference of properties of each prescription
[0072] Table 3 Multiple comparison results of scores of each group (all pairs, Tukey-Kramer HSD)
[0073] Note: Levels not connected by the same letter are significantly different
[0074] The results (Tables 2 and 3) show that the order of taste scores for the different prescriptions is: Prescription 3, 2, 4, 1, 5, 6, 7. Prescriptions 3, 2, and 4 scored higher and had better taste, with Prescription 3 having the highest score for sweet and sour palatability. Compositions with a high proportion of stachyose in the formulation resulted in an overly sweet taste, such as in Prescription 1. A high proportion of aloe vera gel powder resulted in a strong sour and astringent taste and other unpleasant tastes, such as in Prescriptions 5, 6, and 7. In summary, a Tukey-Kramer HSD multiple comparison of prescriptions 1-7 revealed that Prescription 3 (aloe vera gel powder to stachyose mass ratio of 1:4) had the best taste, followed by Prescription 2 (1:9) and Prescription 4 (3:7).
[0075] Example 2: Comparison of dissolution rates of compositions with different ratios
[0076] According to the formulation in Table 1 of Example 1, 5 g of the powder of Recipes 1-7 was accurately weighed and placed in a 100 mL beaker with 50 mL of purified water. The mixture was heated to 40°C with magnetic stirring at 50 rpm. 5 g of the powdered composition was then added to the beaker, and the time it took for the powder to completely dissolve was recorded. Three experiments were performed for each formulation.
[0077] The experimental results, shown in Table 4, show that as the proportion of stachyose in the formulation increases, the dissolution time decreases in a dose-dependent manner, indicating that stachyose increases the solubility of aloe vera gel powder. Formulations 1, 2, and 3 dissolve quickly and at a good dissolution rate. Aloe vera gel powder is quite sticky and tends to stick to the sides of the container when dissolved in water, resulting in poor dissolution. Combining it with stachyose significantly improves the dissolution of aloe vera gel powder and increases its dissolution rate.
[0078] Table 4 Time for complete dissolution of each prescription at 40°C (min), n=3
[0079] Example 3: Toxic effects of stachyose, aloe vera gel powder, and combinations of aloe vera gel powder and stachyose in different ratios on RAW264.7 and CT26 cells
[0080] The cytotoxic effects of aloe vera gel powder (AGF), stachyose (STC), and the combination of aloe vera gel powder and stachyose (AS) on RAW264.7 and CT26 cells were investigated through in vitro cytotoxicity experiments on mouse mononuclear macrophage cells RAW264.7 and mouse colon cancer cells CT26.
[0081] (1) Experimental methods
[0082] (1) Related solution configuration
[0083] RPMI-1640 / DMEM complete medium: Add 50 ml of premium fetal bovine serum and 5 ml of penicillin-streptomycin solution to 500 ml of RPMI-1640 / DMEM medium, mix well, and place in a 4°C refrigerator until use.
[0084] AGF mother solution: Accurately weigh 400 mg of AGF into a 15 ml centrifuge tube, add 10 ml of PBS solution, mix well, filter through a 0.22 μm microporous membrane, and place in a 4°C refrigerator for later use.
[0085] STC stock solution: Accurately weigh 160 mg of STC into a 15 ml centrifuge tube, add 10 ml of PBS solution, mix well, filter through a 0.22 μm microporous membrane, and store in a 4°C refrigerator until ready for use.
[0086] Prescription 1-7 stock solution: Accurately weigh 200 mg of each of Prescription 1-7 into a 15 ml centrifuge tube, add 10 ml of PBS solution, mix well, filter through a 0.22 μm microporous membrane, and place in a 4°C refrigerator for later use.
[0087] (2) Cell culture
[0088] Mouse colon cancer cells CT26 were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum and 1% penicillin. When the cells reached 80% confluence, they were trypsinized and centrifuged for passage and plating.
[0089] Mouse mononuclear macrophage RAW264.7 cells were cultured in DMEM high-glucose medium supplemented with 10% fetal bovine serum and 1% penicillin. When the cells reached 80% confluence, they were gently scraped with a cell scraper and centrifuged for passage and plating.
[0090] (3) Cell viability determination
[0091] CCK-8 is an upgraded alternative to MTT. Based on WST-8, it is a rapid, highly sensitive, and non-radioactive assay widely used for cell proliferation and cytotoxicity. Therefore, the CCK-8 assay was used to investigate the effects of various concentrations of AGF, STC, and their combination on the viability of CT26 and RAW264.7 cells.
[0092] a. The seeding concentration in a 96-well plate was 1×10 5 100 μl / well of cell suspension, and the culture plate was placed in a 37°C, 5% CO2 incubator for 12 h to allow the cells to adhere;
[0093] b. Dilute the mother solution of the relevant solution with complete medium according to the concentration in Table 5 and add 100 μL to the corresponding wells. Set up 6 parallel wells for each concentration and place the culture plate in the incubator for 48 hours;
[0094] c. Add 10 μl of CCK-8 solution to the culture plate, taking care not to create bubbles, and place the culture plate in the incubator for 2 hours;
[0095] d. Use a microplate reader to measure the absorbance at 450 nm and calculate the cell survival rate and cell inhibition rate according to the following formula.
[0096] As: absorbance of the experimental well (containing cells, culture medium, CCK-8 solution and test solution)
[0097] Ac: Absorbance of control well (containing cells, culture medium, CCK-8 solution)
[0098] Ab: absorbance of blank well (containing culture medium and CCK-8 solution)
[0099] Table 5 In vitro study concentrations of stachyose, aloe vera gel powder and the combination
[0100] (2) Experimental results
[0101] (1) Effects of different concentrations of aloe vera gel powder (AGF) on the proliferation of macrophage RAW264.7 cells
[0102] Different concentrations of AGF affect the cell viability of RAW264.7 cells. As shown in Figure 1A, compared with the control group, 24 hours after administration, when the concentration of AGF was 6.45-40 μg / ml, there was no significant effect on cell growth. When the concentration of AGF was greater than or equal to 60 μg / ml, the cell viability of RAW264.7 was reduced and the growth was significantly inhibited ( ** P<0.01). As shown in Figure 1B, compared with the control group, 48 hours after administration, when the concentration of AGF was less than 20 μg / ml, there was no significant effect on cell growth. When the concentration of AGF was greater than or equal to 20 μg / ml, the cell viability of RAW264.7 cells decreased and the growth was significantly inhibited ( ** P < 0.01), and compared with 24 h, the cell survival rate at 48 h was slightly decreased. When the AGF concentration was greater than or equal to 190.5 μg / ml, the cell survival rate was less than 50%.
[0103] (2) Effects of different concentrations of stachyose (STC) on the proliferation of macrophage RAW264.7 cells
[0104] Different concentrations of STC had an effect on the cell viability of RAW264.7 cells. As shown in Figure 2A, compared with the control group, 24 hours after administration, when the concentration of STC was 9.5-100 μg / ml, there was no significant effect on cell growth. When the concentration of STC was greater than or equal to 160 μg / ml, the cell viability of RAW264.7 was significantly increased ( ** P<0.01), when the concentration was 140 μg / ml, the cell viability was significantly increased compared with the control group ( * P<0.05). As shown in Figure 2B, compared with the control group, 48 hours after administration, when the concentration of STC was 9.5-100 μg / ml, there was no significant effect on cell growth. When the concentration of STC was greater than or equal to 140 μg / ml, the cell viability of RAW264.7 cells was significantly increased ( ** P < 0.01), and the cell viability at 48 h was slightly increased compared with that at 24 h.
[0105] (3) Effect of the ratio of aloe vera gel powder (AGF) and stachyose (STC) on the proliferation of macrophage RAW264.7
[0106] As shown in Figure 3A, compared with the control group, 24 hours after administration, the AGF and STC ratios of different prescriptions all affected the cell viability of RAW264.7 cells. Among them, the cell viability of the STC group, prescription 1, prescription 2 and prescription 3 was generally significantly higher than that of the control group ( ** P < 0.01), were 103.2%, 102.9%, 102.7% and 102.6% respectively. The cell viability of AGF group, prescription 4, prescription 5, prescription 6 and prescription 7 was generally significantly lower than that of the control group ( ** P<0.01) and prescription 3 ( ## P < 0.01), which were 89.0%, 72.8%, 60.7%, 57.2%, and 54.6%, respectively. As shown in Figure 3B, compared with the control group, the effects of STC and AGF, as well as each formulation, on RAW264.7 cells were more pronounced after 48 hours of administration, as compared with the 24-hour trend. This indicates that after 24 and 28 hours of administration, when the mass proportion of STC is greater than or equal to 80%, it can promote the proliferation of RAW264.7 cells, while vice versa, it inhibits proliferation.
[0107] (4) Effects of different concentrations of aloe vera gel powder (AGF) on the proliferation of colon cancer cells CT26
[0108] Different concentrations of AGF affect the cell viability of CT26 cells. As shown in Figure 4A, compared with the control group, 24 hours after administration, when the concentration of AGF was 0.032 mg / ml, there was no significant effect on cell growth. When the concentration of AGF was 0.1 mg / ml, the cell viability of CT26 was significantly inhibited ( * P<0.05), when the concentration of AGF was greater than or equal to 0.2 mg / ml, the cell viability of CT26 was extremely significantly inhibited ( ** P<0.01). As shown in Figure 4B, compared with the control group, 48 hours after administration, when the concentration of AGF was 0.032 mg / ml, there was no significant effect on cell growth. When the concentration of AGF was greater than or equal to 0.1 mg / ml, the cell viability of CT26 was extremely significantly inhibited ( ** P < 0.01), and the cell viability at 48 h was slightly decreased compared with that at 24 h.
[0109] (5) Effects of different concentrations of stachyose (STC) on the proliferation of colon cancer cells CT26
[0110] Different concentrations of STC had no effect on the cell viability of CT26 cells. As shown in Figures 5A and 5B, there was no significant difference between the various dosing groups, indicating that at a given STC concentration, the cell viability of CT26 cells was not affected.
[0111] (6) Effect of the ratio of aloe vera gel powder (AGF) and stachyose (STC) on the proliferation of mouse colon cancer cells CT26
[0112] As shown in Figure 6A and B, compared with the control group, the cell viability of CT26 cells in the AGF group, prescription 3, prescription 4, prescription 5, prescription 6, and prescription 7 was inhibited 24 h and 48 h after administration ( ** P < 0.01), the 24h cell survival rates were 89.7%, 84.4%, 71.7%, 68.6%, 64.7% and 58.9%, respectively, and the 48h cell survival rates were 85.1%, 76.3%, 69.7%, 65.6%, 54.2% and 51.4%, respectively. This shows that when the mass proportion of AGF is greater than or equal to 20%, it can inhibit the proliferation of CT26 cells, and the inhibitory effect increases with time.
[0113] In summary, when the mass ratio of aloe vera gel powder (AGF) and stachyose (STC) is 1:4 (prescription 3), it can inhibit the proliferation of mouse colon cancer cells CT26 (AGF: 0.2 mg / ml, STC: 0.8 mg / ml), exert an anti-tumor effect, and promote the proliferation of mouse mononuclear macrophages RAW264.7 (AGF: 40 μg / ml, STC: 160 μg / ml), exerting an immune regulatory effect. Therefore, this ratio was used for the CT26 tumor-bearing mouse experiment.
[0114] Example 4: Study on the anti-tumor effect of aloe vera gel powder, stachyose, and a combination of aloe vera gel powder and stachyose (1:4) on colon cancer in mice
[0115] (1) Experimental methods
[0116] (1) Cell culture
[0117] Mouse colon cancer cells CT26 were selected and cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum and 1% penicillin. When the cells reached 80% growth, they were digested with trypsin, centrifuged, and the cell volume was adjusted to 1.0×10 7 pieces / mL.
[0118] (2) Establishment of colon cancer mouse model
[0119] Experimental Animals: 24 SPF-grade male BALB / c mice, aged 6-8 weeks and weighing 20 (± 2) g, were provided by Liaoning Changsheng Biotechnology Co., Ltd., Animal Certification Number: SYXK (Liao) 2020-0001. Housing environment: Standard SPF animal room, temperature: (23 ± 2) °C, relative humidity: 50%-60%, light and dark cycles of 12 h each, mice had free access to water and feed. All animals in this experiment were housed in the Shenyang Pharmaceutical University Animal House in accordance with the animal husbandry regulations of Shenyang Pharmaceutical University, and animal experimental procedures were conducted under the guidance of the Laboratory Animal Protection Association.
[0120] After 2 weeks of adaptive feeding, the mice were inoculated with CT26 wild-type cells. The lower abdomen of the mice was depilated and disinfected, and a 1 mL microsyringe was used to extract a CT26 cell suspension (1.0 × 10 7 / mL) were inoculated into the left lower abdomen of mice, with 0.1mL (1×10 6 pieces / pieces).
[0121] As shown in Figure 7 , the day of injection was marked as D0, and the tumor volume was 0. The mice were kept under SPF conditions for 7 days (D7). The results showed that the average tumor volume was not less than 62.5 cm 3 , the subcutaneous tumor model of colon cancer was successfully constructed.
[0122] (3) Mouse grouping
[0123] The model mice were divided into a normal saline group, a stachyose group, an aloe vera gel powder group, and a combination of aloe vera gel powder and stachyose group, with 6 mice in each group. 3 The time was recorded as the start of the experiment day 0, and gavage was started. The corresponding solution or normal saline was gavaged once a day (9:00 am) for 21 consecutive days. The dosage of each group was as follows:
[0124] 1.) The normal saline group was given normal saline at 10 ml / kg / day
[0125] 2.) Stachyose group was given 80 mg / kg / d of stachyose aqueous solution
[0126] 3.) Aloe vera gel powder group was given aloe vera gel powder aqueous solution at 20 mg / kg / d
[0127] 4.) The aloe vera gel powder and stachyose combination group was given a combination solution at a stachyose dose of 80 mg / kg / d and an aloe vera gel powder dose of 20 mg / kg / d.
[0128] (4) Measurement of mouse tumor volume
[0129] Starting from the first day of tumor cell inoculation, the diameter (a) and short diameter (b) of the tumor were measured once daily (9:00 am) with a vernier caliper, and the tumor volume was calculated and a tumor growth curve was plotted. After the start of oral gavage, tumor size was measured daily, and the tumor volume was calculated and a tumor growth curve was plotted.
[0130] (5) Mouse sampling
[0131] 24 hours after the last oral administration, the mice were killed by cervical dislocation, the tumors were carefully removed, washed in ice-cold saline, dried, and the tumor weight was weighed and the tumor inhibition rate was calculated.
[0132] On the 21st day, the mice were anesthetized, their eyes were removed to collect blood, and then they were killed by cervical dislocation. The liver and spleen were carefully removed, washed with ice-cold saline, dried, weighed, and the organ index was calculated. The mice were then stored at -80°C for later use.
[0133] On day 21, mice were anesthetized, their eyeballs removed, and blood was collected. The blood was incubated at 37°C for 2 hours, centrifuged at 3500 rpm, and then at 4°C for 20 minutes. The pale yellow serum fraction was carefully aspirated and stored at -80°C until further use. Kits were used to detect cytokines IgG (immunoglobulin G), IgM (immunoglobulin M), IFN-γ (interferonγ), TNF-α (tumor necrosis factor α), pro-inflammatory cytokines IL-1β (interleukin-1β), IL-6 (interleukin-6), and anti-inflammatory cytokines IL-10 (interleukin-10).
[0134] (6) HE staining of mouse tumors
[0135] Fresh mouse tumor tissue was fixed in paraformaldehyde for 24 h, then placed in 50% ethanol, 60% ethanol, 70% ethanol, 80% ethanol, 90% ethanol, 95% ethanol I, 95% ethanol II, anhydrous ethanol I, and anhydrous ethanol II for dehydration for 0.5 h, then placed in anhydrous ethanol xylene solution (1:1) for 10 min, xylene I for 5 min, and xylene II for 5 min to make it transparent, and finally placed in 58°C-60°C paraffin I and paraffin II for 1 h each, embedded, and sectioned after the paraffin solidified.
[0136] The cut tissue was placed in a 60°C oven for 1 h, and then placed in xylene, anhydrous ethanol, 90% ethanol, 80% ethanol, 70% ethanol, and RO water for rehydration, and then HE staining was performed according to the kit.
[0137] (7) Flow cytometry detection of immune cells in mouse spleen and tumor
[0138] Spleen tissue pretreatment
[0139] 1.) Preparation: Prepare 1.5 mg / mL collagenase IV solution (prepared in HBSS), prepare a six-well plate and crushed ice, and place the six-well plate on ice.
[0140] 2.) Sampling: Place the removed spleen in a six-well plate (to keep the spleen fresh)
[0141] 3.) Disintegration: Add 1.8 mL of collagenase IV solution to each spleen and mince with small scissors (cut as finely as possible, do not use a homogenizer or cell disruptor). Clean the scissors when operating on different samples.
[0142] 4.) Digestion: Use a rubber-tipped dropper to transfer the minced tissue homogenate into a 4 mL EP tube. Place in a 37°C water bath for digestion for 1 hour. Take out the sample and vortex for 30 minutes. Repeat the water bath and vortexing for about 2 times.
[0143] 5.) Adjust the volume: Use the filter to filter small amounts multiple times, discard the large pieces of tissue at the bottom of the EP tube, add whole blood and tissue diluent to the filtered sample, and adjust the volume to 2 mL.
[0144] Cell isolation and labeling
[0145] The above-mentioned fixed volume sample was taken and extracted using a mouse spleen tissue lymphocyte isolation kit (Beijing Solebow Technology Co., Ltd.).
[0146] CD8 marker + T cells, Treg cells: Add CD3, CD4, and CD8 antibodies, add 1 μL to each sample, vortex and incubate on ice in the dark for 20 minutes. After using the FOXP3 kit to disrupt the nucleus, add 1 μL of Foxp3 antibody and incubate on ice for 20 minutes (the working solution is prepared according to the instructions). Centrifuge at 4°C, 500g, 10 minutes. After centrifugation, discard the supernatant, add 200 μL Cell Staining Buffer to each sample, blow evenly, pass through a sieve, add 200 μL Cell Staining Buffer (or add 400 μL Cell Staining Buffer, blow evenly directly, pass through a sieve), and detect on the machine (place at 4°C in the dark). CD3, CD4 and CD8 antibodies are used to mark CD8 +T cells, CD3, CD4, and Foxp3 antibodies were used to label Treg cells.
[0147] To label monocytes: Centrifuge 500 μL of sample at 500 g for 10 minutes at 4°C. Discard the supernatant and add 200 μL of Cell Staining Buffer. Resuspend evenly. Add 1 μL of CD14 antibody, vortex, and incubate on ice for 20 minutes in the dark. Add 200 μL of Cell Staining Buffer to the sample, pipette evenly, pass through a sieve, and analyze (store in the dark at 4°C).
[0148] To label DCs: Add 1 μL of CD8, CD86, and CD11c antibodies to each sample, vortex, and incubate on ice for 20 minutes in the dark. Centrifuge 500 μL of sample at 500 g for 10 minutes at 4°C. Discard the supernatant and add 200 μL of Cell Staining Buffer. Resuspend evenly. Add 1 μL of the antibody cocktail, vortex, and incubate on ice for 20 minutes in the dark. Add 200 μL of Cell Staining Buffer to the sample, pipette evenly, pass through a sieve, and analyze (store at 4°C in the dark).
[0149] (8) Data statistics
[0150] All data and plots were statistically analyzed using Graphpad 8.0 software. Measurement data were expressed as ± SEM. One-way analysis of variance was used for comparison among multiple groups, and LSD-t test was used for pairwise comparison. * P<0.05 indicates that the difference is significant. ** P<0.01 indicates extremely significant differences.
[0151] (2) Experimental results
[0152] (1) Stachyose and aloe vera gel powder-stachyose combination significantly improved the spleen index of CT26 tumor-bearing mice
[0153] As shown in Figure 8, the spleen index represents the immune status of mice. After tumor inoculation, cancer cells stimulate the spleen, causing immune cells to overactivate and swell, resulting in increased spleen mass and increased spleen index. Studies have shown that an increase in spleen index is negatively correlated with the prognosis of colon tumors. After administration of stachyose, the spleen index was significantly reduced ( ** P < 0.01), indicating that stachyose improved the swelling caused by tumor. The spleen index of the aloe vera gel powder group did not change significantly compared with the saline group. In the composition, the spleen index was significantly reduced compared with the saline group ( ** P<0.01). This suggests that the combination is superior to aloe vera gel powder alone in improving the spleen index of CT26 tumor-bearing mice.
[0154] (2) Aloe vera gel powder and its composition significantly inhibited tumor growth in CT26 tumor-bearing mice
[0155] As shown in Figure 9, at the beginning of the experiment (days 0-7), there was almost no difference in tumor size and growth rate among the mice groups. From day 8 to day 21, tumors in the saline group grew rapidly, while tumor growth was inhibited in the stachyose group, aloe vera gel powder group, and combination group.
[0156] On the 21st day, the mice were euthanized and the tumors were removed and weighed. The results are shown in Figure 10. Compared with the normal saline control group, the tumor weights of each experimental group were significantly reduced ( ** P<0.01, the tumor weight of the combination group was the smallest, and the tumor inhibition effect was better than that of the stachyose group ( ## P<0.01) and aloe vera gel powder group ( # P<0.01).
[0157] (3) Effect of aloe vera gel powder and stachyose combination on tumor histopathology in CT26 colon cancer-bearing mice
[0158] As shown in Figure 11, after HE staining of tumor tissue sections, observation under a 200x (20×10) light microscope showed that the tumor cells in the normal saline group were round, oval, polygonal, larger in size, with darker nuclei, larger nucleoplasm, more nuclear divisions, and less nuclear pyknosis. In the aloe vera gel powder group and the stachyose group, the tumor cells were partially necrotic and uneven in size. At the same time, the immune cells in the aloe vera gel powder group increased, indicating that both had a certain killing effect on tumor cells. The immune cells in the combination group increased, and the tumor cells were necrotic over a large area, almost losing their cell morphology, with blurred edges and loose arrangement. The nuclei were more fragmented and pyknized, the chromatin was crescent-shaped, the nuclear-cytoplasmic ratio was reduced, the cell division period was less, and the tumor tissue showed varying degrees of swelling, vacuoles, and necrosis. This shows that the combination has a significant inhibitory effect on tumors in tumor-bearing mice, and its effect is better than that of the aloe vera gel powder group and the stachyose group.
[0159] (4) Effect of aloe vera gel powder and stachyose combination on cytokines in mouse serum
[0160] (4.1) IL-1β
[0161] IL-1β is primarily secreted by neutrophils infiltrating the lesion site. Solid tumors in which IL-1β is upregulated include breast cancer, colon cancer, lung cancer, head and neck cancer, and melanoma. Patients with IL-1β-producing tumors generally have a poor prognosis. Furthermore, interleukin IL-1β can promote the growth of colorectal cancer cells through the miR-181a / PTEN axis.
[0162] As shown in FIG12 , when mice were given aloe vera gel powder, stachyose and the combination, the IL-1β levels in the serum of mice in the aloe vera gel powder group, the stachyose group and the combination group were significantly decreased ( ** P < 0.01), with the combination group showing the best effect. Administration of aloe vera gel powder, stachyose, and the combination reduced serum IL-1β levels in mice, suggesting a potent anti-inflammatory and anti-tumor effect.
[0163] (4.2)IL-6
[0164] The pathological role of IL-6 in disease progression has been demonstrated in animal models of many diseases, and blocking IL-6 through gene knockout or administration of anti-IL-6 or anti-IL-6R antibodies can lead to the prevention or therapeutic inhibition of disease progression. IL-6 is also a core driver of cancer metastasis. Within the tumor microenvironment, IL-6 can directly act on disseminated cancer cells (DCCs) in the primary lesion, promoting their invasive ability through trans-receptors on the surface of primary tumor cells and inducing interference with the immune system.
[0165] As shown in FIG12 , when mice were given aloe vera gel powder, stachyose and the combination, the IL-6 levels in the serum of mice in the aloe vera gel powder group, the stachyose group and the combination group were significantly decreased ( ** P < 0.01), with the combination group showing the best effect. Administration of aloe vera gel powder, stachyose, and the combination reduced serum levels of the immune-suppressing cytokine IL-6 and the invasiveness of cancer cells in mice, with the combination demonstrating the strongest IL-6 inhibition effect.
[0166] (4.3)IL-10
[0167] In the treatment of tumors, the increase of IL-10 can inhibit the biological effects of anti-tumor immune response and make tumor cells immune tolerant. In addition, excessive IL-10 macrophage infiltration produces regulatory T cell infiltration and CD8 + T cell dysfunction is characterized by immune escape from the tumor microenvironment, leading to metastasis. Therefore, low expression of IL-10 may indicate a certain inhibitory effect on tumor metastasis.
[0168] As shown in FIG12 , when mice were given aloe vera gel powder, stachyose and the combination, the IL-10 levels in the serum of mice in the aloe vera gel powder group, the stachyose group and the combination group were significantly decreased ( **P < 0.01), with the combination group showing the best effect. Administration of aloe vera gel powder, stachyose, and the combination reduced serum levels of the immunosuppressive cytokine IL-10, suggesting enhanced anti-tumor immune responses. The combination had the strongest IL-10 inhibitory effect.
[0169] (4.4) IgG and IgM
[0170] Immunoglobulins (Ig) are a class of globulins with antibody activity and are an important component of the body's disease resistance. They are widely present in blood, tissue fluids, and exocrine fluids. According to traditional theory, only B lymphocytes and plasma cells can produce immunoglobulins. However, recent studies have shown that various cancer cells (such as breast cancer, lung cancer, cervical cancer, and colorectal cancer) can also express immunoglobulins, especially immunoglobulin G (IgG). Tumor-derived immunoglobulins are detrimental to tumor treatment, mainly leading to tumor proliferation and metastasis, and tumor immune escape.
[0171] As shown in FIG12 , when mice were given aloe vera gel powder, stachyose, and the combination, the levels of IgG and IgM as a biomarker in the serum of mice in the aloe vera gel powder group, the stachyose group, and the combination group were significantly decreased ( ** P < 0.01), and the decrease was most significant in the combination group, indicating that the tumor in the combination group was inhibited.
[0172] (4.5)IFN-γ
[0173] Interferon-γ (IFN-γ) is a soluble dimeric cytokine with antiviral, anti-tumor, and immune regulatory effects. It can regulate the expression levels of 30 genes, generating a variety of cellular responses. It can promote NK cell activity, enhance antigen presentation, and increase macrophage lysosomal activity.
[0174] As shown in FIG12 , when mice were given aloe vera gel powder, stachyose and the combination, the IFN-γ levels in the serum of mice in the aloe vera gel powder group, the stachyose group and the combination group were significantly increased ( ** P < 0.01), with the combination group showing the most significant increase. Administration of aloe vera gel powder, stachyose, and the combination increased serum IFN-γ levels in mice, activating the immune system's defenses and exerting anti-tumor effects. The combination was more effective in increasing IFN-γ than either stachyose or aloe vera gel powder alone.
[0175] (4.6)TNF-α
[0176] TNF is a cytokine that can cause hemorrhagic necrosis in tumor tissue. Tumor necrosis factor is divided into TNF-α and TNF-β based on its source and structure. TNF-α is primarily produced by monocytes and macrophages activated by lipopolysaccharide, and plays a key role in regulating immune responses and inducing apoptosis in target cells.
[0177] As shown in FIG12 , when mice were given aloe vera gel powder, stachyose and the combination, the TNF-α level in the serum of the mice in the combination group was significantly increased ( ** P<0.01), and there was also a significant difference compared with the aloe vera gel powder group ( # P<0.05). The combination increased the level of TNF-α in the serum of mice, induced apoptosis of target cells, and inhibited tumor growth.
[0178] (5) Flow cytometry detection of immune cells in the spleen of different groups of colon cancer mice
[0179] (5.1) Monocytes
[0180] Monocytes are the largest blood cells and the largest white blood cells, and are a crucial component of the body's defense system. Monocytes participate in immune responses, transferring the antigenic determinants they carry to lymphocytes after phagocytizing them, thereby inducing specific immune responses.
[0181] As shown in FIG13 , after administration of aloe gel powder, stachyose and the combination, the proportion of monocytes in the spleen tissue of mice increased, and the proportion of monocytes in the stachyose group, aloe gel powder group and the combination was significantly higher than that in the normal saline group ( ** P<0.01), and the combination still had significant effect compared with the aloe vera gel powder group and the stachyose group ( ## P<0.01). Oral administration of aloe vera gel powder, stachyose, and the combination promoted the proliferation of monocytes in the spleen of mice.
[0182] (5.2) Dendritic cells
[0183] Dendritic cells (DCs) are antigen-presenting cells that can take up, process and present antigens, initiating T cell-mediated immune responses.
[0184] As shown in FIG13 , after administration of aloe vera gel powder, stachyose, and the combination, the proportion of DC cells in the spleen tissue of mice increased. The proportions of DC cells in the stachyose group, aloe vera gel powder group, and the combination group were significantly higher than those in the normal saline control group. Although the proportion of DC cells in the combination group was lower than that in the normal saline control group, it was still significantly higher than that in the normal saline control group ( **P<0.01). Oral administration of aloe vera gel powder, stachyose, and the combination promoted DC cell proliferation in the spleen of mice and enhanced T cell-mediated immune response.
[0185] (5.3)CD8 + T cells
[0186] CD8 + T cells generally refer to cytotoxic T lymphocytes. Cytotoxic T lymphocytes (CTLs), a subtype of white blood cells, are specialized T cells that secrete various cytokines and participate in immune responses. They have a killing effect on certain antigens, such as viruses and tumor cells.
[0187] As shown in FIG13 , after administration of aloe vera gel powder, stachyose and the combination, CD8 + The proportion of T cells increased, and the stachyose group, aloe vera gel powder group and the combination group were significantly higher than those in the normal saline group ( ** P<0.01), and the combination still had significant effect compared with the aloe vera gel powder group and the stachyose group ( ## P<0.01). Oral administration of aloe vera gel powder, stachyose and the combination increased the number of CD8 + The proportion of T cells can then increase the production of immune anti-tumor cytokines in the body.
[0188] (5.4) Treg cells
[0189] Regulatory T cells (Treg) are a cell subset with significant immunosuppressive effects. Treg cells can secrete inhibitory cytokines such as IL-10, enabling tumor cells to resist the apoptosis-induced effects of immune effector cells.
[0190] As shown in FIG13 , after administration of aloe vera gel powder, stachyose, and the combination, the proportion of Treg cells in the spleen tissue of mice decreased, but only the aloe vera gel powder group and the aloe vera gel powder stachyose group showed significant differences compared with the saline group ( * P<0.05). Oral administration of aloe vera gel powder, stachyose, and the combination reduced the proportion of Treg cells in the spleen of mice, reduced the immunosuppressive factors in the mice, and thus enhanced the immune system's ability to kill tumor tissue.
[0191] The present invention combines aloe vera gel powder with stachyose to increase the tumor inhibition rate, which plays a synergistic role. Compared with taking aloe vera gel powder alone, the composition of aloe vera gel powder and stachyose can significantly improve the spleen index of tumor-bearing mice and increase the positive factors in the spleen of mice for anti-tumor. When aloe vera gel powder, stachyose and the composition are administered, monocytes, CD8 +The proportions of T cells and DC cells increased, while factors that are unfavorable to anti-tumor activity were significantly reduced, namely, the proportion of Treg cells was significantly downregulated. Furthermore, the combination was more effective than using stachyose alone or aloe vera gel powder alone.
[0192] Example 5: Effect of the composition on intestinal flora in mice with colon cancer
[0193] (1) Experimental methods
[0194] The CT26 tumor-bearing mouse modeling method, grouping, and composition ratio were the same as in Example 4. At 9:00 am the day before euthanasia, the mice were wiped with alcohol cotton and placed in a clean bench. Sterile forceps were used to stimulate the perianal area of the mice. The collected feces were placed in sterile cryovials, rapidly frozen with liquid nitrogen, and stored at -80°C for intestinal flora sequencing and short-chain fatty acid content determination.
[0195] (2) Experimental results
[0196] α diversity analysis mainly includes species evenness analysis and species richness analysis. Among them, the Shannon diversity index and the Simpson index are the main indicators for measuring the evenness of bacterial species. The Shannon diversity index represents the total number of individuals and the number of each species in the community, while the Simpson index represents the total number of species in the community and the proportion of a certain species in all species. The Chao index and the Ace index are the main indicators for measuring the species richness of the bacterial community. The Chao index is obtained by taking the quotient of the number of species containing 1 individual and the number of species containing 2 individuals, and the Ace (Abundance-based Coverage Estimator) index analyzes the number of species less than a certain individual. In short, the Chao index and the Ace index pay more attention to the existence of rare species. As shown in Figure 14, compared with the saline group, the Shannon diversity index of the combination group increased significantly ( * P<0.05), indicating that the composition can increase the species diversity of the bacterial flora in the feces of mice with colon cancer. As shown in Figure 14, compared with the saline group, the Chao index and Ace index, which represent the abundance of bacterial species, were significantly increased in the composition group and the aloe vera gel powder group ( * P < 0.05, and the combined group index was the highest ( ** P<0.01), indicating that the composition can increase the abundance of bacterial flora in the feces of mice with colon cancer.
[0197] OTU (Operational Taxonomic Units) is a unique marker artificially assigned to a taxonomic unit (strain, species, genus, group, etc.) in order to facilitate analysis in phylogenetic studies or population genetics studies.
[0198] As shown in Figure 15a, compared with the saline group, the number of OTUs in the feces of mice in the composition group increased significantly ( ** P < 0.01), and as shown in Figure 15b, the number of unique OTUs in the composition group was the largest, indicating that the composition increased the types of intestinal flora in mouse feces. At the same time, as shown in Figure 16, compared with the normal saline group, the probiotics unclassified-Oscillatory Spirochaete, unclassified-Lachnospira, Roseburia, Oscillatoria, Lachnospiraceae-NK4A136 and Segmented Filamentous Bacteria in the feces of mice in the composition group increased significantly ( * P<0.05), increased by 4.3 times, 4.5 times, 8.6 times, 5.1 times, 8.8 times and 2.8 times respectively. (Chen H et al, Frontiers in immunology, 2020, 11: 588079; Chattopadhyay I et al, Applied biochemistry and biotechnology, 2021, 193: 1780-1799; Wolfe AE et al, PLoS one, 2020, 15(7): e0236595; Wang Q et al, Applied microbiology and biotechnology, 2020, 104: 5915-5928.) And as shown in Figure 17a-b, compared with the saline group, the harmful bacteria Amoeba and the total number of harmful bacteria in the feces of mice in the composition group were significantly reduced ( * The gut microbiota may modify the susceptibility and progression of CRC by regulating mechanisms such as inflammation and DNA damage, as well as producing metabolites involved in tumor progression or suppression. Intestinal dysbiosis was observed in CRC patients, with a decrease in commensal bacterial species (butyrate-producing bacteria) and an enrichment in harmful bacterial groups (pro-inflammatory opportunistic pathogens).
[0199] The composition of aloe vera gel powder and stachyose can significantly increase the number of intestinal probiotics, unclassified Oscillating Spirochetes, unclassified Lachnospira, Roseburia, Oscillating Bacterium, Lachnospiraceae-NK4A136, segmented filamentous bacteria and the total number of beneficial bacteria, and reduce the number of harmful bacteria Amoeba and the total number of harmful bacteria.
[0200] Example 6: Effect of the composition on the content of short-chain fatty acids in mouse feces
[0201] (1) Experimental methods
[0202] The CT26 tumor-bearing mouse modeling method, grouping, and composition ratio were the same as in Example 4. Fecal sample collection was performed according to Example 4. Frozen fecal samples were weighed and placed in 2 mL EP tubes. 1 mL of pure water was added and vortexed for 10 seconds. Steel balls were added and the mixture was milled at 40 Hz for 4 minutes, ultrasonicated for 5 minutes (in an ice-water bath), and repeated three times. The sample was centrifuged at 4°C and 5000 rpm for 20 minutes. 0.8 mL of the supernatant was transferred to a 2 mL EP tube. 0.1 mL of 50% H2SO4 was added, and 0.8 mL of the extract (containing the internal standard 2-methylvaleric acid, 25 mg / L, methyl tert-butyl ether) was added. The mixture was vortexed for 10 seconds, shaken for 10 minutes, and ultrasonicated for 10 minutes (in an ice-water bath). The sample was centrifuged at 4°C and 10000 rpm for 15 minutes. The mixture was allowed to stand at -20°C for 30 minutes. The supernatant was removed and placed in an injection vial for GC-MS analysis.
[0203] The instrument was a Shimadzu GC2030-QP2020NX gas chromatograph-mass spectrometer. The system used an HP-FFAP capillary column; 1 μL of analyte was injected in split mode (5:1); helium was used as the carrier gas, and the front inlet purge flow rate was 3 mL min -1 The gas flow rate through the column was 1 mL min -1 The initial temperature was 80℃ and maintained for 1 min, then the temperature was increased at 10℃ min -1 The temperature was raised to 200 °C at a rate of 100 °C, maintained for 5 min, and then increased to 40 °C min -1 The temperature of the ionization reaction was raised to 240°C at a rate of 100°C and held for 1 minute. The injection, transfer line, quadrupole, and ion source temperatures were 240°C, 240°C, 150°C, and 200°C, respectively. The energy was -70 eV in electron impact mode. Mass spectra were acquired in scan / SIM mode after a 3.5-minute solvent delay over the m / z range of 33–150.
[0204] The detected fatty acids were acetic acid, propionic acid, butyric acid, isobutyric acid, isovaleric acid, valeric acid, and hexanoic acid. The peaks of each component were determined by retention time, and the peak areas were calculated to obtain the concentrations of each fatty acid. The total amount of short-chain fatty acids in mouse feces was obtained by summing them up.
[0205] (2) Experimental results
[0206] Short-chain fatty acids are metabolites produced by the fermentation of dietary fiber by colonic intestinal flora. They can not only maintain the proliferation of normal colon epithelial cells and promote the recovery of the intestinal barrier, but also significantly antagonize the proliferation of intestinal tumor cells and promote tumor cell apoptosis.
[0207] As shown in Figure 18, the effect on the acetic acid content in mouse feces. Compared with the saline group, the acetic acid content in the feces of mice in the composition group was significantly increased ( ** P<0.01).
[0208] Effect on the content of propionic acid in mouse feces. Compared with the saline group, the content of propionic acid in the feces of mice in the aloe vera gel powder group and the combination group increased significantly ( * P < 0.05; ** P<0.01), and compared with the aloe vera gel powder group and the stachyose group, the propionic acid content in the feces of the mice in the combination group was significantly increased ( # P < 0.05; ## P<0.01).
[0209] Effect on the isobutyric acid content in mouse feces. Compared with the saline group, the isobutyric acid content in the feces of mice in the aloe vera gel powder group, stachyose group and combination group was significantly increased ( * P<0.05).
[0210] Effects on butyric acid content in mouse feces. Compared with the saline group, the butyric acid content in the feces of mice in the aloe vera gel powder group, stachyose group and combination group increased significantly ( * P < 0.05; ** P<0.01), and the combination group was superior to the single drug group ( ## P<0.01).
[0211] Effect on the total content of SCFAs in mouse feces. Compared with the saline group, the total content of SCFAs in the feces of mice in the aloe vera gel powder group and the combination group increased significantly ( * P < 0.05; ** P<0.01), and the combination group was superior to the single drug group ( ## P<0.01). This suggests that oral administration of the composition can increase the amount of short-chain fatty acids in the intestine, which is beneficial to the integrity and reconstruction of the intestinal barrier and inhibits the growth and metastasis of intestinal tumors.
[0212] Therefore, the composition of aloe vera gel powder and stachyose of the present invention can significantly increase the amount of intestinal short-chain fatty acids including but not limited to acetic acid, propionic acid, butyric acid, isobutyric acid, isovaleric acid, valeric acid and caproic acid.
[0213] In summary, the present invention's combination of aloe vera gel powder and stachyose significantly improves the taste and solubility of the aloe vera gel powder. Cell experiments unexpectedly revealed that this aloe vera gel powder and stachyose combination can inhibit the growth of colon cancer cells without significantly affecting the proliferation of macrophages.
[0214] Through animal experiments, it was unexpectedly discovered that this composition can better increase the number of intestinal probiotics, reduce the number of harmful bacteria and the amount of short-chain fatty acids, and has a better effect in improving immunity.
Claims
1. A composition of aloe vera gel powder and stachyose, It is characterized in that The invention comprises aloe vera gel powder and stachyose, wherein the mass ratio of the aloe vera gel powder to the stachyose is 1:30-20:1, more preferably 1:9-3:7, and most preferably 1:3-1:
5.
2. The composition of aloe vera gel powder and stachyose according to claim 1, It is characterized in that The aloe vera gel powder has a polysaccharide content greater than or equal to 80 mg / g and an O-acetyl content greater than or equal to 90 mg / g.
3. Use of aloe vera gel powder or the composition according to claim 1 or 2 in the preparation of anti-tumor food, medicine or health care product.
4. The use according to claim 3, It is characterized in that The tumors include but are not limited to colorectal tumors.
5. The use according to claim 3 or 4, It is characterized in that The aloe vera gel powder or the composition according to claim 1 or 2 increases the infiltration of immune cells in colorectal tumor tissues, promotes the necrosis of colorectal cancer cells, and exerts an immune anti-tumor effect.
6. The use according to claim 3 or 4, It is characterized in that The aloe vera gel powder or the composition according to claim 1 or 2 exerts an anti-tumor effect by increasing the anti-tumor cytokines TNF-α and IFN-γ and reducing the IL-1β, IL-6 and IL-10 cytokines that promote tumor deterioration.
7. The use according to claim 3 or 4, It is characterized in that The aloe vera gel powder or the composition according to claim 1 or 2 improves the CD8 + It can reduce the number of T cells and DC cells and reduce the number of immunosuppressive cells Treg cells to exert anti-tumor effects.
8. The use according to claim 3 or 4, It is characterized in that The aloe vera gel powder or the composition according to claim 1 or 2 exerts an anti-tumor effect by regulating intestinal flora, increasing the number of probiotics and reducing the number of harmful bacteria.
9. The use according to claim 3 or 4, It is characterized in that The aloe vera gel powder or the composition according to claim 1 or 2 exerts an anti-tumor effect by increasing the content of short-chain fatty acids in the intestine and improving intestinal health.
10. Use of aloe vera gel powder or the composition according to claim 1 or 2 in preparing foods, medicines or health products for regulating immunity, regulating intestinal flora or increasing intestinal short-chain fatty acids.
11. Use of stachyose or the composition according to claim 1 or 2 in preparing food, medicine or health product for improving spleen index.
12. The composition of claim 1 or 2 improves the mouthfeel and dissolution rate of aloe vera gel powder.
Citation Information
Patent Citations
New pharmacologic application of aloe polysaccharide
CN101879180A
Compound traditional Chinese medicine extract and application thereof
CN103705409A
Fruit enzyme particles and preparation process thereof
CN105661512A
Aloe barbadensis enzyme drink and preparation method thereof
CN107535782A
Aloe polysaccharide as well as preparation method and application thereof
CN109320626A
